GlassScriptPhysician profile
Mark S Godfrey
NPI 1235576554
$6,914.83
in general payments reported to CMS, 2019-2025
17 companies · $3,016 in 2025
The $3,016 reported for 2025 was more than what 83% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.99 · 2021: $878 · 2022: $1,679 · 2023: $394 · 2024: $848 · 2025: $3,016.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Food and Beverage: $1,500 · Travel and Lodging: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Food and Beverage | $1,500.32 |
| Travel and Lodging | $257.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,187.68 | 2023-2025 | Da Vinci Surgical System |
| Ethicon INC. | $2,054.16 | 2021-2025 | Monarch Platform |
| Pulmonx Corporation | $447.99 | 2022-2023 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Davol INC. | $271.12 | 2023-2024 | Progel Applicator Spray Tips |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $148.52 | 2024 | |
| Abbott Laboratories | $139.91 | 2024 | Cardiomems |
| Galvanize Therapeutics, INC | $135.32 | 2024 | Aliya System |
| Medical Device Business Services, INC. | $127.00 | 2022 | |
| Glaxosmithkline, LLC. | $102.32 | 2021-2022 | |
| Genentech USA, INC. | $99.99 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $45.81 | 2021 | |
| Mylan Specialty L.P. | $41.31 | 2021 | |
| Jazz Pharmaceuticals INC. | $38.05 | 2021 | |
| Eisai INC. | $24.46 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.51 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $15.25 | 2022 | |
| Ambu INC. | $14.43 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Godfrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.